dihexa solubility in dmso mg ml mg/ml Non-aqueous, zwitterionic solvent as an alternative for dimethyl sulfoxide the life sciences Dihexa is concentrated in multiple – DIHEXA PEPTIDE 10MG VIAL –

Proangiogenic effects : BPC 157 may also promote angiogenesis (new blood vessel formation)

BPC-157 is not FDA approved for any human therapeutic use

GHK-Cu is a small, naturally occurring copper peptide (a tripeptide, meaning three amino acids: glycine, histidine, lysine) bound to a single copper ion

Key Features Blend strength: BPC-157 10 mg + TB-500 10 mg per vial (20 mg total) Pack size: 10 vials/kit (bulk supply available on request) Format: lyophilized powder for stable storage and handling in lab workflows Supplier positioning: China-based factory supply with export-ready cartons and secure packing Documentation: batch labeling and order coordination support for repeat wholesale buyers Typical Research Focuses Recovery-support and tissue-repair pathway models (non-clinical, research settings) Mobility & training-load recovery study frameworks (protocol-based, lab handling required) Stack compatibility research and stability handling for lyophilized peptide formats General peptide handling, storage, and logistics workflows for distributors Packaging & Ordering Standard inner packing: 10-vial plastic trays with bubble wrap and foam protection Outer packing: export-ready cartons with insulation and protective materials suitable for international transit Flexible order quantities starting from 1 kit for sample evaluation